Hematopoietic bone marrow is a regenerative tissue of high clinical relevance, yet relatively little is known about the metabolism of the stem and progenitor populations concerned. We have used a multipotent murine cell line to generate sufficient numbers of cells undergoing self-renewal, erythroid or myeloid differentiation to allow a proteomics analysis of enriched mitochondria. Stringent analysis identified 37 mitochondria-associated proteins changing on differentiation in this system. Those induced during differentiation were commonly associated with mature cell functions, while those inactivated upon differentiation indicate widespread changes in mitochondrial transport, fatty acid catabolism and oxidative phosphorylation. An erythroid specific reduction in glutamate pyruvate amino transferase 2 was confirmed at the protein level by western blotting and at the functional level by assays of metabolite turnover.
Introduction
Blood cell production in the bone marrow is regulated by a range of well characterised signaling molecules, but also by a metabolic environment about which we know relatively little. Recent studies suggest that the long-lived multipotent hematopoietic stem cells are maintained in a hypoxic niche, run a predominantly glycolytic metabolism and limit the accumulation of potentially damaging reactive oxygen species [1] . As these stem cells exit quiescence, a switch to fatty acid oxidation may provide the energy required for the initial divisions that generate both replacement stem cells and the multipotent progenitors that enter proliferative haematopoiesis [2] . However, the subsequent metabolism of proliferative differentiation along the various blood cell lineages is poorly characterized.
The two major products of hematopoiesis are erythroid cells and neutrophilic granulocytes.
The early cell divisions in each lineage generate structurally similar blast cells with a high nucleus to cytoplasmic ratio, while later divisions are accompanied by progressive, lineagespecific changes. Neutrophils are high-energy cells poised to play an active role in host defense. The final stages of their maturation involve extensive biosynthesis and biogenesis to generate secretory granules and mitochondria poised to execute an oxidative burst [3] . In contrast, the final stages of erythropoiesis involve rounds of reductive division followed by extrusion of the nuclei and loss of the mitochondria. The emerging erythrocytes retain an exclusively cytoplasmic metabolism that serves primarily to provide protection against oxidative stress [4] . While the biosynthetic demands of progenitor proliferation are therefore similar for both lineages, the later stages of maturation are likely to have different metabolic requirements.
With the aim of comparing metabolic activities characteristic of proliferative differentiation along these two major lineages, we have studied erythroid and granulocytic differentiation of the multipotent murine precursor cell line, FDCP-Mix. The FDCP-Mix cells proliferate in the presence of high concentrations of interleukin-3 (IL-3) as a population of multipotent progenitors retaining the potential to generate both erythroid and myeloid cells. Transfer of these multipotent cells to media containing low concentrations of IL-3 together with either myeloid or erythroid growth factors supports proliferative differentiation along the corresponding lineage, culminating after a few days in post-mitotic maturation [5, 6] . A proportion of the erythroid cells undergo enucleation and the mature neutrophils survive for a short time only, as is the case in vivo. The FDCP-Mix cells therefore provide a suitable model for studies requiring large numbers of hematopoietic cells at defined stages of differentiation.
We report here a proteomics analysis of mitochondria purified from FDCP-Mix at various stages of differentiation that reveals stage and lineage-specific features, including an unexpected shift in glutamine metabolism during erythroid differentiation.
Materials and Methods

Cell culture
Multipotent FDCP-Mix cells were maintained in IMDM containing 5 mM glucose, 2 mM glutamine, 20 % pre-tested horse serum and 10 U/ml mIL-3 (Peprotech). Cells were passaged every two days to maintain the density between 6 x 10 4 and 5 x 10 5 per ml. All culture procedures were carried out in an uninterrupted low oxygen atmosphere (5% O 2 , 5% CO 2 in N 2 ). Otherwise, differentiation was induced essentially as previously reported [5] .
Glucose was replenished on the third day of myeloid differentiation. For experiments involving the determination of metabolite levels in culture supernatants, the serum was dialyzed extensively against PBS (10 kilodalton cut-off) to remove small metabolites. Human umbilical cord blood blood was collected following local ethical committee approval and informed consent of the parents. Mononuclear cells were purified over Lymphoprep (Stem Cell Technologies) and CD34 + cells isolated by MACS (Miltenyi Biotech). Lineage specific differentiation was achieved by culture in IMDM, 10% FCS for 10 days in the presence of 25 U/ml SCF, 100 U/ml GM-CSF and 200 U/ml G-CSF for myeloid cells and for 12 days in the presence of 25 U/ml SCF, 2 U/ml erythropoietin and 500 nM dexamethasone for erythroid cells.
Monitoring differentiation state
Cell morphology was assessed by staining cytospun cells with May-Gruenwald / Giemsa with the inclusion of o-dianidisine to identify haemaglobinised cells. The frequency of clonogenic cells, capable of continued self-renewal in high interleukin 3 was measured by seeding 1000 cells in 3 ml of methylcellulose self-renewal medium into each well of a 6-well plate [5, 6] .
Plates were incubated at 37 °C, 5% CO 2 in humidified air for 14 days before counting the number of visible colonies, all of which have undifferentiated morphology.
The following antibodies were used for FACS analysis: CD11b-APC (BioLegend); Ter-119-FITC (BioLegend); CD117-PE-Cy7 (BD Pharmingen) and anti-Sca-1-PE (BD Pharmingen).
FACS analysis was performed using a BD LSR II flow cytometer and BD FACSDiva Software, version 6.1.3.
Isolation of mitochondria
Mitochondria were isolated by hypotonic lysis, dounce homogenization, preclearing by centrifugation and then separation over a sucrose step gradient [7] . See supporting information for details.
Capillary isoelectric focusing immunoassay
The analysis of equal portions of each interface fraction was performed on a NanoPro 1000 instrument (proteinsimple, San Jose, CA) according to the manufacturer's instructions.
Mouse-anti-ATP-synthase (Life technologies, 1:25) was used as the primary antibody, followed by an anti-mouse-biotin secondary antibody and streptavidin-HRP (proteinsimple, 1:100).
iTRAQ labeling
Pellets of the mitochondria-enriched interface fraction were resuspended in lysis buffer (0 
Western Blotting
Proteins were blotted from a 12% polyacrylamide gel to nitrocellulose and probed with an affinity purified rabbit anti Gpt2 antibody (Sigma AV48996) or anti-Tomm20 monoclonal (clone 4F3, Sigma), followed by peroxidase-labelled secondary antibodies and detection by chemiluminescence. Whole transferred protein was visualized by Ponceau staining.
Metabolite assays
FDCP-Mix cells from the various stages of differentiation were washed and seeded at 10 6 per ml in fresh medium. Two independent experiments were performed, each with 5 replicates per condition. 18hr culture-conditioned media were snap frozen and stored at -80 o C.
Glucose was measured using the Glucose liquicolor kit (Human GmbH, Wiesbaden), lactate with a photometric assay [9] , glutamine using a photometric assay [10] and glutamate using a published amino acid / acyl carnitine LC-MS/MS assay [11] . The changes in absolute metabolite concentration were calculated in comparison to control supernatants prepared from triplicate samples of cell-free media that had undergone the same experimental procedures. Mean and standard deviation were calculated (n=10). An independent twosample t-test was performed and statistical significance was defined as p < 0.05.
Results
Cell differentiation and the preparation of mitochondria
When cultured in myeloid or erythroid differentiation medium, FDCP-Mix cells typically undergo a period of proliferative differentiation lasting 5-7 days, followed by post-mitotic maturation [5, 6] . 
Mass spectrometry and data analysis
Liquid chromatography tandem mass spectrometry (LC-MS/MS) of iTRAQ labeled peptides was used to determine relative protein abundance in the mitochondria-enriched fractions. A total of 2168 proteins were identified in the entire data set. proteins was reduced further by excluding proteins for which (i) information was derived from data on less than 3 peptides or a ratio count < 3 or (ii) the ratio variability between peptides representing the same protein exceeded 60%.
This procedure generated a stringent set of 119 high-confidence "changing proteins". Of 
Proteins increasing during differentiation
Ten proteins registered an increase during myeloid differentiation only (Fig. 3A) and a further 2 during both myeloid and erythroid differentiation (Fig. 3B) . Five of these 12 proteins (Gsr, Six mitochondria-associated proteins increased above the threshold level during erythroid differentiation but show very little change during myeloid differentiation (Fig. 3C) . Two of the most strongly induced, ferrochetalase (Fech) and protoporphyrin oxidase (Ppox), are involved in heme synthesis. Two others, acyl coA synthetase (Acss1) and sterol carrier protein 2 (Scp2), mediate the synthesis and transfer of cholesterol, which is present at high concentration in erythrocyte membranes [14] . Catalase (an antioxidant already known to be highly expressed in erythrocytes) and Ap2m1 (an ATPase proton pump subunit of unclear significance) accumulated to modest levels.
Proteins decreasing during differentiation
Nineteen proteins decreased during differentiation, 17 of which tended to decrease in both Two mitochondrial proteins stand out as decreasing in a lineage-specific manner. One of these, the ATP-binding cassette transporter Abcf2, is a mitochondrial transporter of unknown function that clearly decreases only under myeloid differentiation conditions. In contrast, the mitochondrial glutamate pyruvate transaminase Gpt2 (EC 2.6.1.2) was depleted during erythroid but not myeloid differentiation. Gpt2 transfers the amino group between glutamate (to generate alpha-ketoglutarate) and pyruvate (to generate alanine). Since the specific decrease of Gpt2 during erythroid differentiation suggests lineage-specific changes in the balance of glutamine metabolism, this change was chosen for validation by western blotting.
Decreased Gpt2 protein levels in erythroid compared to myeloid cells were confirmed using independent differentiation cultures of FDCP-Mix and of human CD34 + progenitor cells (Fig.   4) . Expression in the human cells was compared to that of Tomm20 as a mitochondrial internal control that had consistently showed no change in the iTRAQ analyses. Having thus confirmed the change in Gpt2 levels, we then looked for direct evidence of a lineage-specific change in glutamine metabolism by measuring the glutamine and glutamate levels in medium conditioned by FDCP-Mix cells at various stages of differentiation. Glucose and lactate levels were determined in parallel as an indicator of glycolytic activity (Fig. 4) .
The uptake of glutamine was comparable in differentiating myeloid and erythroid populations.
However, the erythroid cells released large amounts of glutamate, while the myeloid cells did not. This pattern is consistent with an inability of the erythroid cells to introduce glutamate into the TCA cycle via the Gpt2-mediated transamination reaction. The biochemical assay therefore provides functional confirmation of the substantial reduction in Gpt2 activity in the erythroid lineage. Glucose uptake was found to increase during early myeloid differentiation and to decrease during erythroid differentiation. Lactate release essentially mirrored glucose uptake, suggesting that, while the extent of glucose catabolism may vary between the lineages (consistent with the increase in Hk1 seen in the myeloid lineage, Fig. 3B ), the proportion of glucose being routed through glycolysis remains largely unchanged.
Discussion
The aim of this study was to identify hematopoietic lineage-and/or stage-specific changes in the expression level of proteins involved in core metabolism by proteomic analysis of mitochondria prepared from various stages of erythroid and myeloid differentiation of a multipotent murine progenitor cell line.
Our results show a high degree of overlap with those of a previous whole-cell proteomics analysis of primary hematopoietic cell populations [15] , with 13 of the 37 high-confidence mitochondrial proteins identified here also having been found to be differentially expressed in primary stem and progenitor cell populations. Furthermore, the 52 "non-mitochondrial"
proteins identified in FDCP-Mix but excluded from the initial analysis also show the bias towards translation and cytoskeletal functions noted in the primary cell study [15] . Furthermore, the related protein VDAC3 was found to be over-represented in primary multipotent progenitors and down-regulated in committed myeloid progenitors [15] , so it will be interesting to determine whether VDAC activity is causally associated with self-renewal.
One of the most striking findings was the consistent decrease in electron transport chain (ETC) protein levels during differentiation along both myeloid and erythroid lineages. In addition to the 8 ETC (and 3 associated) proteins that were flagged as high-confidence changes, targeted re-analysis of the data revealed a total of 48 ETC components in the complete data set, most of which follow a similar (if less extreme) pattern of expression (not shown). The reduction in CPT1 over this same period suggests that the self-renewing state of FDCP-Mix draws energy primarily from oxidative phosphorylation of acetyl CoA derived from the ß oxidation of fatty acids. This is consistent with an increasing body of evidence connecting fatty acid oxidation (FAO) with homeostatic self-renewal [2, 17] .
If energy production from FAO decreases during commitment and differentiation, it seems likely that the proliferative differentiation process uses alternative energy sources. Glycolysis, measured by glucose uptake and lactate release, was particularly high during the early proliferative phase of myeloid differentiation. We also detected a strong increase in HK1 in the myeloid lineage and although it must be borne in mind that the mitochondria-associated hexokinase proteins detected here are not necessarily a reliable indicator of total cytoplasmic glycolysis, these observations suggest that glucose does become a major substrate in cells undergoing myelopoiesis. It is possible that glucose-derived acetyl CoA is also used to drive the TCA cycle. However, there were myeloid-specific increases in a number of other mitochondrial enzymes that either use or generate acetyl CoA: Enoyl CoA hydratase (Echs1; ß-oxidation of fatty acids); citrate lyase (Clyb1; malate synthesis) and 3-hydroxy-3-methylglutaryl-coenzyme A lyase (Hmgcl; ketone body metabolism). This suggests that acetyl CoA flux may change significantly during myelopoiesis and may be a particularly informative focus for further studies.
There was no increase in glycolysis during erythroid differentiation. However, the degree of FDCP-Mix proliferation during erythroid differentiation is far lower than that during myeloid differentiation, so there is insufficient evidence to conclude a difference in anabolic glycolytic flux between the two lineages. What does stand out during erythroid differentiation is the specific down-regulation of the enzyme glutamine pyruvate transaminase 2 (Gpt2) suggesting a decreased capacity for glutaminolysis that we were able to confirm by direct measurement of glutamine uptake and glutamate release. This raises questions concerning the role of glutamine in erythropoiesis. Firstly, it cannot be ruled out that the FDCP-Mix cells experience an artefactual block in glutaminolysis that limits proliferation. Indeed, it has recently been reported that the glutamine transporter ASCT2 is essential for erythropoiesis, and that erythroid progenitors use exogenous glutamine for nucleoside synthesis [18] .
However, the fact that these cells express glutamine synthase, and that at least some progenitors can undergo erythropoiesis in the absence of glutamine [18] suggests that the situation is probably more complex.
This highlights an important consideration in analyses of metabolic activity in cultured cells, in that key features of cellular metabolism may become apparent only in the specialized nutrient environment of the appropriate niche. Our use of reduced oxygen conditions is one step in this direction. However, in following up the findings reported here it may be necessary to progressively adapt the culture conditions to reflect more accurately the (still unknown)
physiological micro-environment of the respective in vivo niche.
In summary, we have succeeded in identifying differences in the metabolism of FDCP-Mix cells undergoing self-renewal versus myeloid and erythroid differentiation. Our work identifies potentially important changes in fatty acid oxidation, glucose and glutamine metabolism, and suggests extensive changes at the level of transport across the mitochondrial membrane.
Further analysis of these changes should lead to a better understanding of the role played by metabolism in haematopoiesis, and enable us to establish more realistic and more effective culture conditions for the amplification or lineage specific haematopoietic differentiation of stem and progenitor cells. 
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